DKK 314.0
(0.26%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.11 Billion DKK | -17.69% |
2022 | 1.35 Billion DKK | 3.96% |
2021 | 1.3 Billion DKK | 46.56% |
2020 | 891.51 Million DKK | -1.39% |
2019 | 904.05 Million DKK | 155.95% |
2018 | 353.21 Million DKK | -6.74% |
2017 | 378.74 Million DKK | -3.28% |
2016 | 391.57 Million DKK | -9.38% |
2015 | 432.12 Million DKK | 10.6% |
2014 | 390.69 Million DKK | 13.2% |
2013 | 345.13 Million DKK | -14.17% |
2012 | 402.09 Million DKK | -16.09% |
2011 | 479.21 Million DKK | 35.63% |
2010 | 353.31 Million DKK | 12.34% |
2009 | 314.49 Million DKK | -4.66% |
2008 | 329.85 Million DKK | -5.66% |
2007 | 349.65 Million DKK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 FY | 1.11 Billion DKK | -17.69% |
2023 Q4 | 1.11 Billion DKK | 5.28% |
2023 Q3 | 1.06 Billion DKK | -13.31% |
2023 Q2 | 1.22 Billion DKK | -4.37% |
2023 Q1 | 1.28 Billion DKK | -5.69% |
2022 Q1 | 1.26 Billion DKK | -3.1% |
2022 FY | 1.35 Billion DKK | 3.96% |
2022 Q4 | 1.35 Billion DKK | 17.6% |
2022 Q3 | 1.15 Billion DKK | -5.71% |
2022 Q2 | 1.22 Billion DKK | -3.24% |
2021 Q1 | 1.2 Billion DKK | 34.94% |
2021 Q3 | 1.11 Billion DKK | -5.98% |
2021 FY | 1.3 Billion DKK | 46.56% |
2021 Q2 | 1.18 Billion DKK | -1.25% |
2021 Q4 | 1.3 Billion DKK | 16.97% |
2020 Q3 | 818 Million DKK | -1.56% |
2020 FY | 891.51 Million DKK | -1.39% |
2020 Q1 | 884 Million DKK | -2.22% |
2020 Q2 | 831 Million DKK | -6.0% |
2020 Q4 | 891.51 Million DKK | 8.99% |
2019 Q3 | 764.1 Million DKK | 9.88% |
2019 Q4 | 904.05 Million DKK | 18.32% |
2019 FY | 904.05 Million DKK | 155.95% |
2019 Q1 | 694.7 Million DKK | 96.68% |
2019 Q2 | 695.4 Million DKK | 0.1% |
2018 Q2 | 342 Million DKK | -6.04% |
2018 Q4 | 353.21 Million DKK | 14.31% |
2018 Q1 | 364 Million DKK | -3.89% |
2018 FY | 353.21 Million DKK | -6.74% |
2018 Q3 | 309 Million DKK | -9.65% |
2017 Q4 | 378.74 Million DKK | 6.69% |
2017 Q2 | 355 Million DKK | -17.25% |
2017 Q1 | 429 Million DKK | 9.56% |
2017 FY | 378.74 Million DKK | -3.28% |
2017 Q3 | 355 Million DKK | 0.0% |
2016 Q1 | 412.2 Million DKK | -4.61% |
2016 FY | 391.57 Million DKK | -9.38% |
2016 Q4 | 391.57 Million DKK | 15.17% |
2016 Q3 | 340 Million DKK | -6.31% |
2016 Q2 | 362.9 Million DKK | -11.96% |
2015 Q3 | 373 Million DKK | -4.9% |
2015 Q4 | 432.12 Million DKK | 15.85% |
2015 FY | 432.12 Million DKK | 10.6% |
2015 Q1 | 406.4 Million DKK | 4.02% |
2015 Q2 | 392.2 Million DKK | -3.49% |
2014 Q3 | 297.9 Million DKK | -16.39% |
2014 FY | 390.69 Million DKK | 13.2% |
2014 Q1 | 367.9 Million DKK | 6.6% |
2014 Q4 | 390.69 Million DKK | 31.15% |
2014 Q2 | 356.3 Million DKK | -3.15% |
2013 Q3 | 333.6 Million DKK | -7.64% |
2013 FY | 345.13 Million DKK | -14.17% |
2013 Q2 | 361.2 Million DKK | -8.72% |
2013 Q1 | 395.7 Million DKK | -1.59% |
2013 Q4 | 345.13 Million DKK | 3.46% |
2012 Q3 | 325.7 Million DKK | -12.75% |
2012 Q2 | 373.3 Million DKK | -12.33% |
2012 Q1 | 425.8 Million DKK | -11.15% |
2012 FY | 402.09 Million DKK | -16.09% |
2012 Q4 | 402.09 Million DKK | 23.46% |
2011 Q1 | 386 Million DKK | 9.25% |
2011 Q2 | 388 Million DKK | 0.52% |
2011 FY | 479.21 Million DKK | 35.63% |
2011 Q4 | 479.21 Million DKK | 0.0% |
2010 Q1 | 320.7 Million DKK | 1.97% |
2010 FY | 353.31 Million DKK | 12.34% |
2010 Q4 | 353.31 Million DKK | 41.27% |
2010 Q3 | 250.1 Million DKK | -16.33% |
2010 Q2 | 298.9 Million DKK | -6.8% |
2009 Q4 | 314.49 Million DKK | 0.0% |
2009 FY | 314.49 Million DKK | -4.66% |
2008 FY | 329.85 Million DKK | -5.66% |
2007 FY | 349.65 Million DKK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Hove A/S | 24.99 Million DKK | -4373.475% |
Novozymes A/S | 14.04 Billion DKK | 92.037% |
SP Group A/S | 1.55 Billion DKK | 28.15% |